欧洲内镜学会:评估内镜局部止血剂 episode artwork

EPISODE · Apr 2, 2026 · 10 MIN

欧洲内镜学会:评估内镜局部止血剂

from 消化肝病前沿资讯

本期播客聚焦内镜止血剂这一前沿话题,从胃肠内镜治疗出血风险切入,详解欧洲胃肠内镜学会评估的六种主流局部止血剂。逐一剖析Purastat、TC-325 Hemospray等产品的作用机制、临床疗效与安全性,对比不同成分与技术的优劣,并探讨医生选择策略及患者知情意义,揭示小小止血剂背后的深厚科学原理与临床智慧。00:06内镜止血剂受关注背景00:43Purastat肽凝胶自组装机制01:37Purastat安全与急性出血疗效02:18Purastat在ESD术后防出血优势03:03TC-325 Hemospray应用与疗效03:47TC-325物理吸附止血机制04:32EndoClot PHS多糖止血特点05:10Nexpowder粉末止血新数据05:50ABS天然植物制剂介绍06:42ABS临床效果与作用未知07:25CG GEL液体凝胶初探08:14六类止血剂机制分类对比09:04止血剂临床选用关键因素09:45止血剂安全性与差异分析10:38患者了解止血剂的意义

Episode metadata supplied by the publisher feed · Published Apr 2, 2026

Embed this episode

Ready to play

欧洲内镜学会:评估内镜局部止血剂

0:00 10:43

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of 消化肝病前沿资讯?

This episode is 10 minutes long.

When was this 消化肝病前沿资讯 episode published?

This episode was published on April 2, 2026.

Can I download this 消化肝病前沿资讯 episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!